|
|
Volumn 20, Issue 2, 2014, Pages 109-
|
|
Big pharma shows signs of renewed interest in RNAi drugs.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG DEVELOPMENT;
DRUG EFFECT;
DRUG INDUSTRY;
ECONOMICS;
METHODOLOGY;
NOTE;
PHARMACOLOGY;
RNA INTERFERENCE;
DRUG DISCOVERY;
DRUG INDUSTRY;
PHARMACOLOGY;
RNA INTERFERENCE;
|
|
EID: 84897577720
PISSN: None
EISSN: 1546170X
Source Type: None
DOI: 10.1038/nm0214-109 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
